Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture

ACS Chem Biol. 2014 Feb 21;9(2):366-71. doi: 10.1021/cb400771y. Epub 2013 Nov 11.

Abstract

CK2 is a protein kinase essential for cell viability whose activity is altered in several cancers. Its mechanisms of regulation differ from those common to other eukaryotic protein kinases and are not entirely established yet. Here we present crystal structures of the monomeric form of the α2β2 holoenzyme that allow refining a formerly proposed structural model for activity regulation by oligomerization. Previous crystal structures of the CK2 holoenzyme show an asymmetric arrangement of the two α catalytic subunits around the obligate β2 regulatory subunits. Asymmetric α2β2 tetramers are organized in trimeric rings that correspond to inactive forms of the enzyme. The new crystal structures presented here reveal the symmetric architecture of the isolated active tetramers. The dimension and the nature of the α/β interfaces configure the holoenzyme as a strong complex that does not spontaneously dissociate in solution, in accordance with the low dissociation constant (∼4 nM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Casein Kinase II / chemistry*
  • Casein Kinase II / metabolism
  • Catalytic Domain
  • Crystallography, X-Ray
  • Humans
  • Models, Molecular
  • Protein Conformation
  • Protein Multimerization
  • Protein Subunits / chemistry
  • Protein Subunits / metabolism

Substances

  • Protein Subunits
  • Casein Kinase II

Associated data

  • PDB/4MD7
  • PDB/4MD8
  • PDB/4MD9